Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2004
09/09/2004US20040175812 Carbohydrates and polyols for dissolving protein crystals
09/09/2004US20040175803 Interferon-alpha induced gene
09/09/2004US20040175798 Expression system for recombinant proteins
09/09/2004US20040175791 DcR3 polypeptide, a TNFR homolog
09/09/2004US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering
09/09/2004US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction
09/09/2004US20040175766 Human pyrimidine receptor
09/09/2004US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome
09/09/2004US20040175714 Human protooncogene kg-20 and protein encoded therein
09/09/2004US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus
09/09/2004DE10309691A1 Isolating cytosol-dissolved proteins from cells of recombinant microorganisms includes precipitating unwanted materials with a cationic surfactant
09/08/2004EP1454917A2 Diabody-type bispecific antibody
09/08/2004EP1454140A2 Diagnosis and treatment of atherosclerosis
09/08/2004EP1453981A1 Methylotrophic bacterium for the production of recombinant proteins and other products
09/08/2004EP1453977A2 Molecular characteristics of non-small cell lung cancer
09/08/2004EP1453966A1 Method for producing a recombinant polypeptide
09/08/2004EP1453963A2 A structure for presenting desired peptide sequences
09/08/2004EP1453956A1 Method for large scale production of virus antigen
09/08/2004EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
09/08/2004EP1453952A2 Compositions and methods for normalizing assays
09/08/2004EP1453948A2 Cell culture process
09/08/2004EP1453858A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
09/08/2004EP1453857A1 Chromatographic purification of recombinant human erythropoietin
09/08/2004EP1453856A1 Beta-amyloid binding factors and inhibitors thereof
09/08/2004EP1453855A1 Antimicrobial bolisin peptides
09/08/2004EP1453854A2 Human cdnas and proteins and uses thereof
09/08/2004EP1453848A2 Sir2 products and activities
09/08/2004EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
09/08/2004EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine
09/08/2004EP1453383A2 A novel saitohin gene and uses of same
09/08/2004EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances
09/08/2004EP1341802A4 In vitro protein synthesis using glycolytic intermediates as an energy source
09/08/2004EP1087995B1 A method for inducing production of growth factors
09/08/2004EP1017802B1 A potential effector for the grb7 family of signalling proteins
09/08/2004EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof
09/08/2004EP0873405B1 Expression augmenting sequence elements (ease) for eukaryotic expression systems
09/08/2004EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules
09/08/2004EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
09/08/2004CN1527941A Methods using 06-alkylguanine-DNA alkyltransferase
09/08/2004CN1527882A Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
09/08/2004CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor
09/08/2004CN1527878A Shingolipid ceramide deacylase gene
09/08/2004CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG)
09/08/2004CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same
09/08/2004CN1527720A Global analysis of protein activities using proteome chips
09/08/2004CN1526821A New glucoamylase and coding its nucleic acid sequence
09/08/2004CN1526820A Promotor for expressing gene in fungal cell
09/08/2004CN1526732A Process for producing high pureness albumin solution
09/08/2004CN1526726A Multisite mutant of human histiotype plasminogen activator
09/08/2004CN1165764C Anti PSMA antibody or antigen binding part, and their use
09/08/2004CN1165618C Polynucleotide immunogenic agents
09/08/2004CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof
09/08/2004CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120
09/08/2004CN1165340C Cartilage/bone inducing materials for reparation
09/08/2004CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
09/07/2004US6788182 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application
09/07/2004US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection
09/07/2004US6787641 Identification of sel-12 and uses thereof
09/07/2004US6787639 Collectin
09/07/2004US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn.
09/07/2004US6787351 Composition for the prevention of preferential viral infections
09/07/2004US6787346 Kinase capable of site-specific phosphorylation of IκBα
09/07/2004US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer.
09/07/2004US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder
09/07/2004US6787168 Peptide product
09/07/2004US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof
09/07/2004US6787137 Campylobacter vaccine
09/07/2004CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs
09/02/2004WO2004074498A2 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
09/02/2004WO2004074497A2 Endomannosidases in the modification of glycoproteins in eukaryotes
09/02/2004WO2004074488A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
09/02/2004WO2004074461A2 Production of modified glycoproteins having multiple antennary structures
09/02/2004WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
09/02/2004WO2004074452A2 Multiplex mapping of protein interactions
09/02/2004WO2004074446A2 Parkin interacting polypeptides and methods of use
09/02/2004WO2004074432A2 Antibody vaccine conjugates and uses therefor
09/02/2004WO2004073393A2 Immunogene adherence and method of making and using same
09/02/2004WO2004053076A3 Methods for rapid detection and identification of bioagents for environmental and product testing
09/02/2004WO2004046365A3 Interferon-alpha polypeptides and conjugates
09/02/2004WO2004036258A3 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays
09/02/2004WO2004022717A3 Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen
09/02/2004WO2004020456A3 Selecting therapeutic human monoclonal antibodies from disease-specific libraries
09/02/2004WO2003048302A3 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
09/02/2004WO2003015697A3 Interleukin-2 mutants with reduced toxicity
09/02/2004US20040172687 Modified proteinase inhibitors
09/02/2004US20040172676 Transforming cells with expression vector comprising early nodulin gene-2 (ENOD2) promoter for use as tissue specific gene regulatory tool; bioreactors and heterologous gene expression
09/02/2004US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants
09/02/2004US20040172670 Maize yellow stripe1 and related genes
09/02/2004US20040171826 Endomannosidases in the modification of glycoproteins in eukaryotes
09/02/2004US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination
09/02/2004US20040171803 Artificial protein having potentiated immunogenicity of epitope
09/02/2004US20040171802 Haemophilus influenzae antigens and corresponding dna fragments
09/02/2004US20040171800 Gamma retinoic acid receptor
09/02/2004US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment
09/02/2004US20040171538 Anticoagulants and their uses
09/02/2004US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control
09/02/2004US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders
09/02/2004US20040171113 Antigens of group b streptococcus and corresponding dna fragments
09/02/2004US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof
09/02/2004US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases